Updated Jul 16, 2026
Tanimoto Sarina is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $9.14M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-08-19 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale | 37.7K | $14.09 | $531K |
| 2025-08-19 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale | 12.3K | $14.03 | $173K |
| 2024-12-19 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 50.0K | $11.67 | $584K |
| 2024-12-19 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 50.0K | $11.67 | $584K |
| 2024-12-11 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 50.0K | $13.16 | $658K |
| 2024-12-11 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 50.0K | $13.17 | $658K |
| 2024-12-09 | SPRY | ARS Pharmaceuticals, Inc. | M — Option exercise | 11.9K | $8.42 | $100K |
| 2024-12-09 | SPRY | ARS Pharmaceuticals, Inc. | M — Option exercise | 11.9K | $8.42 | $100K |
| 2024-12-09 | SPRY | ARS Pharmaceuticals, Inc. | M — Option exercise | 13.8K | $1.44 | $20K |
| 2024-11-21 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 50.0K | $13.95 | $697K |
| 2024-11-21 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 50.0K | $13.95 | $698K |
| 2024-11-14 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 4.9K | $17.64 | $86K |
| 2024-11-14 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 45.1K | $16.76 | $756K |
| 2024-11-14 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 5.0K | $17.64 | $87K |
| 2024-11-14 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 45.0K | $16.76 | $755K |
| 2024-10-17 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 50.0K | $14.88 | $744K |
| 2024-10-17 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 1.4K | $15.25 | $22K |
| 2024-10-17 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 48.5K | $14.86 | $722K |
| 2024-10-10 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 50.0K | $13.83 | $691K |
| 2024-10-10 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 50.0K | $13.83 | $691K |
Tanimoto Sarina is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 17 open-market sales ($9.14M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Tanimoto Sarina profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.